Details

Autor(en) / Beteiligte

• Shangguan, Shida
• Ehrenberg, Philip K
• Geretz, Aviva
• Butler, Lauryn
• Pinyakorn, Suteeraporn
• Sriplienchan, Somchai
• Sacdalan, Carlo
• Chomchey, Nitiya
• Phanuphak, Nittaya
• Tovanabutra, Sodsai
• Vasan, Sandhya
• Hsu, Denise
• Thomas, Rasmi

Titel

HLA-B57 and B58 Associate with Predictors of Reservoir Size in an Acutely Treated HIV Cohort

Ist Teil von

• AIDS research and human retroviruses, 2023-03, Vol.39 (3), p.114-118

Ort / Verlag

United States

Erscheinungsjahr

2023

Quelle

MEDLINE

Beschreibungen/Notizen

• Much has been learnt about the role of human leukocyte antigen (HLA) alleles during natural infection of HIV-1, but far less is known about their role in people living with HIV (PLWH) on suppressive antiretroviral therapy (ART). In this study we used variable selection to identify predictors of HIV reservoir size, as measured by total HIV DNA in 192 participants in an acute HIV infection (AHI) cohort. Baseline clinical data including pre-ART CD4 T cell counts and plasma viral load (VL) were available from all participants along with longitudinal measurements after ART initiation during AHI. Time to VL suppression, time to CD4 reconstitution, and pre-ART viremia were the strongest predictors of undetectable total HIV DNA at 24 weeks after ART initiation. We next performed HLA typing in 526 participants from the same cohort and investigated associations with the three predictors of reservoir size. HLA-B*57 and B*58 both associated significantly with time to VL suppression, which was one of the predictors of the size of the HIV reservoir. These findings are significant in PLWH and have to be considered in the context of therapeutic intervention when conducting analytic treatment interruption studies as participants with these alleles could impact clinical findings given the small sizes of these studies.